祝贺!生物医学领域4位华人学者当选2019年美国人文与科学院院士!

2019-04-19 佚名 医药观澜

生命科学及化学领域有4名华人学者入选美国人文与科学院院士。

4月17日,美国人文与科学院(American Academy of Arts and Sciences)正式公布了2019年最新当选的院士名单,共有200多名新院士。我们很高兴地看到在生命科学及化学领域有4名华人学者入选美国人文与科学院院士。

美国人文与科学院成立于1780年,是美国历史悠久的独立学术团体和政策研究中心。通过吸纳来自学界、商界、以及政府部门的领袖,该学院期望通过在人文、艺术、教育、科学、工程、技术等领域的研究,协助政策制定,解决全球所面临的种种挑战。

目前,该学院已有超过4900位院士及外籍院士,其中包括超过250位诺贝尔奖得主和60多位普利策奖得主。能够入选美国人文与科学院,也是对这些学者所取得成就的一大认可。

以下华人学者按姓名首字母排序:

1程亦凡院士 – 生物科学



程亦凡院士目前任职于美国加州大学旧金山分校(UCSF)。早年学习物理,后转行进入结构生物学领域,在冷冻电镜(cryo-EM)方面取得的突破成果令人瞩目。冷冻电镜是继X射线晶体学和核磁共振技术之后,又一结构生物学研究利器。2016年初,英国学术杂志《自然·方法》在年度最受关注技术榜单中将其放在首位。2013年,程亦凡教授和David Julius教授合作,利用冷冻电镜技术成功解析了辣椒素受体TRPV1原子分辨率的结构,至此掀起了结构生物学领域内“冷冻电镜革命”。

2冯国平院士 – 生物科学



冯国平院士现任麻省理工学院(MIT)大脑与认知科学系McGovern大脑研究所讲席教授,致力于了解调节大脑突触发育和功能的机制,以及突触功能障碍如何导致精神疾病。他创建的绿色荧光蛋白转基因小鼠模型在神经生物学界得到了广泛应用。近年,冯教授的实验室结合尖端技术和多学科方法,揭示神经发育和精神疾病的神经生物学机制。

3金亦石院士 – 生物科学



加州大学圣地亚哥分校(UCSD)神经生物学系教授金亦石早年于北京大学取得学士学位,后在加州大学伯克利分校取得博士学位,后于MIT进行博士后研究,现在主要利用模式生物线虫进行神经系统发育和功能方面的研究,旨在将基本机制与人类神经障碍和神经元修复的理解联系起来。

4余金权院士 – 化学



余金权院士现任美国斯克利普斯研究所教授,中科院上海有机所特聘研究员,被认为是国际上C-H键活化领域最为活跃的华人学者。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1910814, encodeId=7359191081475, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jan 30 12:32:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976274, encodeId=7ddb19e62744e, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jan 03 07:32:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458339, encodeId=2ae0145833936, content=<a href='/topic/show?id=502b24940b3' target=_blank style='color:#2F92EE;'>#人文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24940, encryptionId=502b24940b3, topicName=人文)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9096012283, createdName=xlwang2693, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461492, encodeId=926f146149216, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582036, encodeId=67dd1582036e2, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623031, encodeId=06c416230315b, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049086, encodeId=e2791049086d9, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Apr 19 12:32:00 CST 2019, time=2019-04-19, status=1, ipAttribution=)]
    2020-01-30 FukaiBao
  2. [GetPortalCommentsPageByObjectIdResponse(id=1910814, encodeId=7359191081475, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jan 30 12:32:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976274, encodeId=7ddb19e62744e, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jan 03 07:32:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458339, encodeId=2ae0145833936, content=<a href='/topic/show?id=502b24940b3' target=_blank style='color:#2F92EE;'>#人文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24940, encryptionId=502b24940b3, topicName=人文)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9096012283, createdName=xlwang2693, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461492, encodeId=926f146149216, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582036, encodeId=67dd1582036e2, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623031, encodeId=06c416230315b, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049086, encodeId=e2791049086d9, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Apr 19 12:32:00 CST 2019, time=2019-04-19, status=1, ipAttribution=)]
    2020-01-03 qjddjq
  3. [GetPortalCommentsPageByObjectIdResponse(id=1910814, encodeId=7359191081475, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jan 30 12:32:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976274, encodeId=7ddb19e62744e, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jan 03 07:32:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458339, encodeId=2ae0145833936, content=<a href='/topic/show?id=502b24940b3' target=_blank style='color:#2F92EE;'>#人文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24940, encryptionId=502b24940b3, topicName=人文)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9096012283, createdName=xlwang2693, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461492, encodeId=926f146149216, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582036, encodeId=67dd1582036e2, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623031, encodeId=06c416230315b, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049086, encodeId=e2791049086d9, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Apr 19 12:32:00 CST 2019, time=2019-04-19, status=1, ipAttribution=)]
    2019-04-21 xlwang2693
  4. [GetPortalCommentsPageByObjectIdResponse(id=1910814, encodeId=7359191081475, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jan 30 12:32:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976274, encodeId=7ddb19e62744e, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jan 03 07:32:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458339, encodeId=2ae0145833936, content=<a href='/topic/show?id=502b24940b3' target=_blank style='color:#2F92EE;'>#人文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24940, encryptionId=502b24940b3, topicName=人文)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9096012283, createdName=xlwang2693, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461492, encodeId=926f146149216, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582036, encodeId=67dd1582036e2, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623031, encodeId=06c416230315b, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049086, encodeId=e2791049086d9, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Apr 19 12:32:00 CST 2019, time=2019-04-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1910814, encodeId=7359191081475, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jan 30 12:32:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976274, encodeId=7ddb19e62744e, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jan 03 07:32:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458339, encodeId=2ae0145833936, content=<a href='/topic/show?id=502b24940b3' target=_blank style='color:#2F92EE;'>#人文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24940, encryptionId=502b24940b3, topicName=人文)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9096012283, createdName=xlwang2693, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461492, encodeId=926f146149216, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582036, encodeId=67dd1582036e2, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623031, encodeId=06c416230315b, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049086, encodeId=e2791049086d9, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Apr 19 12:32:00 CST 2019, time=2019-04-19, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1910814, encodeId=7359191081475, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jan 30 12:32:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976274, encodeId=7ddb19e62744e, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jan 03 07:32:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458339, encodeId=2ae0145833936, content=<a href='/topic/show?id=502b24940b3' target=_blank style='color:#2F92EE;'>#人文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24940, encryptionId=502b24940b3, topicName=人文)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9096012283, createdName=xlwang2693, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461492, encodeId=926f146149216, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582036, encodeId=67dd1582036e2, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623031, encodeId=06c416230315b, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049086, encodeId=e2791049086d9, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Apr 19 12:32:00 CST 2019, time=2019-04-19, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1910814, encodeId=7359191081475, content=<a href='/topic/show?id=fa64e9729d1' target=_blank style='color:#2F92EE;'>#美国人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79729, encryptionId=fa64e9729d1, topicName=美国人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7b6284, createdName=FukaiBao, createdTime=Thu Jan 30 12:32:00 CST 2020, time=2020-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976274, encodeId=7ddb19e62744e, content=<a href='/topic/show?id=ac3fe4911c3' target=_blank style='color:#2F92EE;'>#科学院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74911, encryptionId=ac3fe4911c3, topicName=科学院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Fri Jan 03 07:32:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458339, encodeId=2ae0145833936, content=<a href='/topic/show?id=502b24940b3' target=_blank style='color:#2F92EE;'>#人文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24940, encryptionId=502b24940b3, topicName=人文)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9096012283, createdName=xlwang2693, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461492, encodeId=926f146149216, content=<a href='/topic/show?id=06a069243aa' target=_blank style='color:#2F92EE;'>#生物医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69243, encryptionId=06a069243aa, topicName=生物医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28b96422769, createdName=wolongzxh, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582036, encodeId=67dd1582036e2, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623031, encodeId=06c416230315b, content=<a href='/topic/show?id=54a7358e4cb' target=_blank style='color:#2F92EE;'>#华人学者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35874, encryptionId=54a7358e4cb, topicName=华人学者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c1720449156, createdName=zhangxingru, createdTime=Sun Apr 21 00:32:00 CST 2019, time=2019-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049086, encodeId=e2791049086d9, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Apr 19 12:32:00 CST 2019, time=2019-04-19, status=1, ipAttribution=)]
    2019-04-19 junJUN

    院士是学术至高点,也是大家必争之地呀

    0

相关资讯

我国生命科学前沿动态与创新战略

我国生命科学研究受到高度重视。 在我国,生命科学研究受到高度重视,被列入了《国家基础研究发展“十二五”专项规划》重点支持领域。此外,我国从1982年就开始陆续实施了攻关、“863”、星火、火炬、“973”、国家科技重大专项、国家重点研发计划等一系列国家科技计划,在人工合成结晶牛胰岛素、超级稻育种技术、提取改造青蒿素治疗疟疾、参与人类基因组计划、新药创制等领域也取得一定的突破

**630亿美元!盘点2018年上半年10大生命科学并购

一晃2018年已过半,上半年并购市场足够强劲,正如安永所预测,2018年生命科学领域并购总值将再超2000亿美元。安永全球生物技术领导人Glen Giovannetti表示,“我们仍然认为,下半年并购活动将保持强劲势头,并将持续到明年。” 本文列举了今年到目前为止,十大生命科学(生物制药和医疗技术领域)已经完成和/或宣布的并购交易。

李克强对2018世界生命科学大会作出重要批示

李克强对2018世界生命科学大会作出重要批示。

颜宁:当科学家是幸福的

当科学家有什么好处?颜宁脱口而出,当科学家是幸福的。

生命科学丨科技部发布2017年度中国科学十大进展

据人民网报道,2月27日下午,科技部基础研究司与科技部基础研究管理中心联合举办“2017年度中国科学十大进展专家解读会”,正式发布2017年度中国科学十大进展。相比去2016年度科技部发布的中国科技十大进展中有6项生命科学领域的成果,2017年的评选结果中生命科学基础研究领域的表现稍显逊色。其中生命科学基础领域成果仅有两项,分别为::北京大学药学院周德敏、张礼和研究组完成的“将病毒直接转化为活疫苗

ChinaBio 合作论坛回归上海 创造空前的生命科学产业跨境合作机遇

第十一届ChinaBio合作论坛将于5月8-9日于作为中国生命科学中心的上海召开。中国目前是全球增长最快的医药市场,并有望在2020年成为全世界最大的市场。本次会议是中国最顶端的生命科学合作论坛,将汇集超过1400名生命科学领域的高管和投资人。 ChinaBio 合作论坛回归上海,创造空前的生命科学产业跨境合作机遇 时间:2019年5月8-9日 地点:中国,上海 主办单位:ChinaBio®,